These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 38273292)

  • 41. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors.
    Vilar E; Salazar R; Pérez-García J; Cortes J; Oberg K; Tabernero J
    Endocr Relat Cancer; 2007 Jun; 14(2):221-32. PubMed ID: 17639039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
    Ji R; Ren Q; Bai S; Wang Y; Zhou Y
    Int J Biol Markers; 2018 Aug; 33(3):254-265. PubMed ID: 29874984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The surgical aspects of the digestive carcinoid tumor].
    García-Sancho Martín L
    An R Acad Nac Med (Madr); 1993; 110(1):145-97. PubMed ID: 8238818
    [No Abstract]   [Full Text] [Related]  

  • 44. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends.
    Song SL; Li B; Carvalho MR; Wang HJ; Mao DL; Wei JT; Chen W; Weng ZH; Chen YC; Deng CX; Reis RL; Oliveira JM; He YL; Yan LP; Zhang CH
    Pharmacol Ther; 2022 Nov; 239():108276. PubMed ID: 36055421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CircRNAs: a new target for the diagnosis and treatment of digestive system neoplasms.
    Li J; Xu Q; Huang ZJ; Mao N; Lin ZT; Cheng L; Sun B; Wang G
    Cell Death Dis; 2021 Feb; 12(2):205. PubMed ID: 33627631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of fusion genes in digestive system cancers: Dawn for cancer precision therapy.
    Zhang Y; Sun J; Song Y; Gao P; Wang X; Chen M; Li Y; Wu Z
    Crit Rev Oncol Hematol; 2022 Mar; 171():103622. PubMed ID: 35124200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features.
    Lin Y; Xu L; Wei W; Zhang X; Ying R
    Biomed Res Int; 2016; 2016():4863609. PubMed ID: 27738631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peritoneal carcinomatosis in patients with digestive endocrine tumors.
    Vasseur B; Cadiot G; Zins M; Fléjou JF; Belghiti J; Marmuse JP; Vilgrain V; Bernades P; Mignon M; Ruszniewski P
    Cancer; 1996 Oct; 78(8):1686-92. PubMed ID: 8859181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bidirectional Mediation Effects between Intratumoral Microbiome and Host DNA Methylation Changes Contribute to Stomach Adenocarcinoma.
    Yue K; Sheng D; Xue X; Zhao L; Zhao G; Jin C; Zhang L
    Microbiol Spectr; 2023 Aug; 11(4):e0090423. PubMed ID: 37260411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoid tumors.
    Robertson RG; Geiger WJ; Davis NB
    Am Fam Physician; 2006 Aug; 74(3):429-34. PubMed ID: 16913162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
    Wang J; Ma X; Si H; Ma Z; Ma Y; Wang J; Cao B
    Mol Med; 2021 Jan; 27(1):1. PubMed ID: 33402118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Carcinoid tumors of the digestive tract. Experience in the Instituto Nacional de la Nutrición Salvador Zubirán].
    Mercado Díaz MA; Aranceta Soto M; Cortés González R; de la Garza Villaseñor L
    Rev Invest Clin; 1985; 37(1):5-10. PubMed ID: 4001620
    [No Abstract]   [Full Text] [Related]  

  • 53. Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review).
    Fu M; Zou C; Pan L; Liang W; Qian H; Xu W; Jiang P; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1207-18. PubMed ID: 27431376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for alimentary cancer: outstanding problems and a new strategy for research.
    Jankowski J; McGarrity TJ
    Eur J Cancer Prev; 1993 May; 2(3):211-4. PubMed ID: 8490538
    [No Abstract]   [Full Text] [Related]  

  • 55. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic potential of long noncoding RNA HOTAIR expression in human digestive system carcinomas: A meta-analysis.
    Abdeahad H; Avan A; Pashirzad M; Khazaei M; Soleimanpour S; Ferns GA; Fiuji H; Ryzhikov M; Bahrami A; Hassanian SM
    J Cell Physiol; 2019 Jul; 234(7):10926-10933. PubMed ID: 30569489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
    Wang M; Yu F; Li P
    Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Digestive system neoplasms originating from the autonomic nervous system. Diagnostic, therapeutic and prognostic issues].
    Rea T; Di Rienzo M; Angelucci D; Tauro A; Sigismondi G; Strassera R; Picardi N
    Ann Ital Chir; 2000; 71(6):677-84. PubMed ID: 11347320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress in research on applying Sijunzi Decoction in treating digestive malignant tumor.
    Wu B; Xuan ZR
    Chin J Integr Med; 2007 Jun; 13(2):156-9. PubMed ID: 17609919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Primary multiple malignant tumors of the digestive tract].
    Fedorov VD; Savchuk BD; Kosarev VA; Tugarinov AI
    Sov Med; 1979 Aug; (8):57-61. PubMed ID: 515828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.